Cargando…
Using ex vivo culture to assess dynamic phenotype changes in human prostate macrophages following exposure to therapeutic drugs
Within the prostate tumor microenvironment (TME) there are complex multi-faceted and dynamic communication occurring between cancer cells and immune cells. Macrophages are key cells which infiltrate and surround tumor cells and are recognized to significantly contribute to tumor resistance and metas...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8481239/ https://www.ncbi.nlm.nih.gov/pubmed/34588590 http://dx.doi.org/10.1038/s41598-021-98903-y |
_version_ | 1784576643319201792 |
---|---|
author | Boibessot, Clovis Joncas, France-Hélène Park, Aerin Berrehail, Zohra Pelletier, Jean-François Gris, Typhaine Bergeron, Alain Toren, Paul |
author_facet | Boibessot, Clovis Joncas, France-Hélène Park, Aerin Berrehail, Zohra Pelletier, Jean-François Gris, Typhaine Bergeron, Alain Toren, Paul |
author_sort | Boibessot, Clovis |
collection | PubMed |
description | Within the prostate tumor microenvironment (TME) there are complex multi-faceted and dynamic communication occurring between cancer cells and immune cells. Macrophages are key cells which infiltrate and surround tumor cells and are recognized to significantly contribute to tumor resistance and metastases. Our understanding of their function in the TME is commonly based on in vitro and in vivo models, with limited research to confirm these model observations in human prostates. Macrophage infiltration was evaluated within the TME of human prostates after 72 h culture of fresh biopsies samples in the presence of control or enzalutamide. In addition to immunohistochemistry, an optimized protocol for multi-parametric evaluation of cellular surface markers was developed using flow cytometry. Flow cytometry parameters were compared to clinicopathological features. Immunohistochemistry staining for 19 patients with paired samples suggested enzalutamide increased the expression of CD163 relative to CD68 staining. Techniques to validate these results using flow cytometry of dissociated biopsies after 72 h of culture are described. In a second cohort of patients with Gleason grade group ≥ 3 prostate cancer, global macrophage expression of CD163 was unchanged with enzalutamide treatment. However, exploratory analyses of our results using multi-parametric flow cytometry for multiple immunosuppressive macrophage markers suggest subgroup changes as well as novel associations between circulating biomarkers like the neutrophil to lymphocyte ratio (NLR) and immune cell phenotype composition in the prostate TME. Further, we observed an association between B7–H3 expressing tumor-associated macrophages and the presence of intraductal carcinoma. The use of flow cytometry to evaluate ex vivo cultured prostate biopsies fills an important gap in our ability to understand the immune cell composition of the prostate TME. Our results highlight novel associations for further investigation. |
format | Online Article Text |
id | pubmed-8481239 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-84812392021-09-30 Using ex vivo culture to assess dynamic phenotype changes in human prostate macrophages following exposure to therapeutic drugs Boibessot, Clovis Joncas, France-Hélène Park, Aerin Berrehail, Zohra Pelletier, Jean-François Gris, Typhaine Bergeron, Alain Toren, Paul Sci Rep Article Within the prostate tumor microenvironment (TME) there are complex multi-faceted and dynamic communication occurring between cancer cells and immune cells. Macrophages are key cells which infiltrate and surround tumor cells and are recognized to significantly contribute to tumor resistance and metastases. Our understanding of their function in the TME is commonly based on in vitro and in vivo models, with limited research to confirm these model observations in human prostates. Macrophage infiltration was evaluated within the TME of human prostates after 72 h culture of fresh biopsies samples in the presence of control or enzalutamide. In addition to immunohistochemistry, an optimized protocol for multi-parametric evaluation of cellular surface markers was developed using flow cytometry. Flow cytometry parameters were compared to clinicopathological features. Immunohistochemistry staining for 19 patients with paired samples suggested enzalutamide increased the expression of CD163 relative to CD68 staining. Techniques to validate these results using flow cytometry of dissociated biopsies after 72 h of culture are described. In a second cohort of patients with Gleason grade group ≥ 3 prostate cancer, global macrophage expression of CD163 was unchanged with enzalutamide treatment. However, exploratory analyses of our results using multi-parametric flow cytometry for multiple immunosuppressive macrophage markers suggest subgroup changes as well as novel associations between circulating biomarkers like the neutrophil to lymphocyte ratio (NLR) and immune cell phenotype composition in the prostate TME. Further, we observed an association between B7–H3 expressing tumor-associated macrophages and the presence of intraductal carcinoma. The use of flow cytometry to evaluate ex vivo cultured prostate biopsies fills an important gap in our ability to understand the immune cell composition of the prostate TME. Our results highlight novel associations for further investigation. Nature Publishing Group UK 2021-09-29 /pmc/articles/PMC8481239/ /pubmed/34588590 http://dx.doi.org/10.1038/s41598-021-98903-y Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Boibessot, Clovis Joncas, France-Hélène Park, Aerin Berrehail, Zohra Pelletier, Jean-François Gris, Typhaine Bergeron, Alain Toren, Paul Using ex vivo culture to assess dynamic phenotype changes in human prostate macrophages following exposure to therapeutic drugs |
title | Using ex vivo culture to assess dynamic phenotype changes in human prostate macrophages following exposure to therapeutic drugs |
title_full | Using ex vivo culture to assess dynamic phenotype changes in human prostate macrophages following exposure to therapeutic drugs |
title_fullStr | Using ex vivo culture to assess dynamic phenotype changes in human prostate macrophages following exposure to therapeutic drugs |
title_full_unstemmed | Using ex vivo culture to assess dynamic phenotype changes in human prostate macrophages following exposure to therapeutic drugs |
title_short | Using ex vivo culture to assess dynamic phenotype changes in human prostate macrophages following exposure to therapeutic drugs |
title_sort | using ex vivo culture to assess dynamic phenotype changes in human prostate macrophages following exposure to therapeutic drugs |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8481239/ https://www.ncbi.nlm.nih.gov/pubmed/34588590 http://dx.doi.org/10.1038/s41598-021-98903-y |
work_keys_str_mv | AT boibessotclovis usingexvivoculturetoassessdynamicphenotypechangesinhumanprostatemacrophagesfollowingexposuretotherapeuticdrugs AT joncasfrancehelene usingexvivoculturetoassessdynamicphenotypechangesinhumanprostatemacrophagesfollowingexposuretotherapeuticdrugs AT parkaerin usingexvivoculturetoassessdynamicphenotypechangesinhumanprostatemacrophagesfollowingexposuretotherapeuticdrugs AT berrehailzohra usingexvivoculturetoassessdynamicphenotypechangesinhumanprostatemacrophagesfollowingexposuretotherapeuticdrugs AT pelletierjeanfrancois usingexvivoculturetoassessdynamicphenotypechangesinhumanprostatemacrophagesfollowingexposuretotherapeuticdrugs AT gristyphaine usingexvivoculturetoassessdynamicphenotypechangesinhumanprostatemacrophagesfollowingexposuretotherapeuticdrugs AT bergeronalain usingexvivoculturetoassessdynamicphenotypechangesinhumanprostatemacrophagesfollowingexposuretotherapeuticdrugs AT torenpaul usingexvivoculturetoassessdynamicphenotypechangesinhumanprostatemacrophagesfollowingexposuretotherapeuticdrugs |